Autonomix Medical to Present at LSI USA ’26

Company Overview - Autonomix Medical, Inc. is a medical device company focused on advancing precision nerve-targeted treatments for diseases involving the nervous system [4] - The company's first-in-class platform technology includes a catheter-based microchip sensing array designed to detect and differentiate neural signals with greater sensitivity than existing technologies [4] - The technology aims to enable transvascular diagnosis and treatment of peripheral nervous system diseases throughout the body [4] Product Development - The initial focus of the technology is on treating pain, specifically targeting pancreatic cancer, which is associated with severe pain and lacks reliable treatment options [5] - The technology serves as a platform for addressing multiple indications, including cardiology, hypertension, and chronic pain management across a wide disease spectrum [5] - The technology is currently investigational and has not yet received marketing clearance in the United States [5] Upcoming Events - Brad Hauser, President and CEO of Autonomix, will present at LSI USA '26 on March 17, 2026, at 9:15 AM PT [1] - Management will also be available for in-person one-on-one meetings with registered investors during the conference [2] - LSI USA '26 is a prominent global medtech summit that brings together executives, investors, and innovators from the healthcare industry [3]